European Commission Greenlights AUCATZYL®: AGC Biologics Marks 10th Regulatory Approval with Autolus’ CAR-T Therapy AGC Biologics, a global contract development and manufacturing organization (CDMO) specializing in biologics and advanced therapies, has reached another significant milestone. On July 21, the European…
Bayer Raises Full-Year Outlook on Strong Pharma Performance, While Setting Aside €1.7 Billion for U.S. Litigation Risks Ahead of its scheduled second-quarter 2025 earnings release on August 6, Bayer AG has issued a significant update to its financial guidance for…
Actio Biosciences Receives FDA IND Clearance and Fast Track Designation for ABS-1230 in KCNT1-Related Epilepsy, Marking Major Advancement in Pediatric Precision Medicine Actio Biosciences, a clinical-stage biotechnology company pioneering novel therapies through the lens of genetics and precision medicine, has…
Novo Nordisk Ushers in New Era of Leadership as Maziar Mike Doustdar Is Named President and CEO, Effective August 7, 2025 Novo Nordisk, a global healthcare leader renowned for its innovations in diabetes and obesity treatment, has announced a major…
Avance Clinical Ushers in a New Era of Trial Excellence Through Strategic Digital Validation Partnership with ValGenesis In a strategic move set to redefine the landscape of clinical research quality management, Avance Clinical, a globally recognized Australian contract research organization…
BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA® in Early-Stage Lung Cancer, Expanding Its Role in Perioperative NSCLC Treatment BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company committed to transforming cancer care through next-generation immunotherapy,…
DiaMedica Therapeutics Secures $30.1 Million in Oversubscribed Private Placement to Bolster Advancement of Neurological and Maternal Health Pipeline Proceeds strengthen company’s financial runway as it targets innovative treatments for preeclampsia, fetal growth restriction, and acute ischemic stroke DiaMedica Therapeutics Inc.…
Flatiron Health Triples Global Oncology Research Network to Power Multinational Real-World Evidence Generation Flatiron Health, a healthtech company pioneering the use of real-world data (RWD) to transform cancer care and accelerate oncology research, has announced a significant milestone: the tripling…
YourChoice Therapeutics Advances Male Contraception with Second Nature Portfolio Publication Showcasing Human Trial Data for YCT-529 YourChoice Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the development of hormone-free contraceptive solutions, has announced a significant milestone with the publication of its…
WuXi Biologics Achieves Major Regulatory Milestone with FDA Pre-License Inspection Clearance for Five Facilities, Including First Commercial Pre-Filled Syringe Site WuXi Biologics (HKEX: 2269), a global leader in Contract Research, Development, and Manufacturing Organization (CRDMO) services, has reached a significant…
Sarepta Therapeutics Responds to FDA’s Voluntary Halt Request for ELEVIDYS Shipments and Clarifies Gene Therapy Safety Concerns Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leading biotechnology company at the forefront of developing precision genetic medicines for rare neuromuscular diseases, issued a…
Propel Health Appoints Veteran Communications Executive Jeff Keller as President of Medical Affairs Business Unit, Signaling Strategic Expansion in Life Sciences Engagement Propel Health, a premier provider of strategic communications and engagement solutions for the life sciences industry, has announced…